Familial hypocalciuric hypercalcemia historical perspective: Difference between revisions

	Familial hypocalciuric hypercalcemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Familial Hypocalciuric Hypercalcemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Familial hypocalciuric hypercalcemia historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Familial hypocalciuric hypercalcemia historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Familial hypocalciuric hypercalcemia historical perspective
CDC on Familial hypocalciuric hypercalcemia historical perspective
Familial hypocalciuric hypercalcemia historical perspective in the news
Blogs on Familial hypocalciuric hypercalcemia historical perspective
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Familial hypocalciuric hypercalcemia historical perspective

Revision as of 14:40, 21 September 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

In the year 1966 FHH was first described by Jackson and Boonstra in a hypercalcemic patient presumed to have Hyperparathyroidism. He wasn't cured despite the removal of three and a half hyperplastic parathyroid glands. Subsequently, seventeen family members with hypercalcemia were identified in three generations^[1]^[2].

A similar family was identified in the year 1972 by Foley Et al. The family members of both the families were asymptomatic and hypercalcemic which is very typical of FHH^[2].

In 1990 ten cases of pancreatitis were reported in patients with family members of FHH^[3].

In 1995 studies were conducted to characterize the mutations of Calcium sensing mutations in FHH and Neonatal hyperparathyroidism^[4].

In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].

@@ Line 14: / Line 14: @@
 * In 1990 ten cases of pancreatitis were reported in patients with family members of FHH<ref name="urlFamilial hypocalciuric hypercalcaemia and pancreatitis: no causal link proven - Stuckey - 1990 - Internal Medicine Journal - Wiley Online Library">{{cite web |url=http://onlinelibrary.wiley.com/doi/10.1111/j.1445-5994.1990.tb00407.x/abstract?systemMessage=Wiley+Online+Library+will+be+unavailable+on+Saturday+7th+Oct+from+03.00+EDT+%2F+08%3A00+BST+%2F+12%3A30+IST+%2F+15.00+SGT+to+08.00+EDT+%2F+13.00+BST+%2F+17%3A30+IST+%2F+20.00+SGT+and+Sunday+8th+Oct+from+03.00+EDT+%2F+08%3A00+BST+%2F+12%3A30+IST+%2F+15.00+SGT+to+06.00+EDT+%2F+11.00+BST+%2F+15%3A30+IST+%2F+18.00+SGT+for+essential+maintenance.+Apologies+for+the+inconvenience+caused+. |title=Familial hypocalciuric hypercalcaemia and pancreatitis: no causal link proven - Stuckey - 1990 - Internal Medicine Journal - Wiley Online Library |format= |work= |accessdate=}}</ref>.
+* In 1995 studies were conducted to characterize the mutations of Calcium sensing mutations in FHH and Neonatal hyperparathyroidism<ref name="urlCalcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.">{{cite web |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC185975/ |title=Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. |format= |work= |accessdate=}}</ref>.
 ==Landmark Events in the Development of Treatment Strategies==